SEROS MEDICAL LLC has a total of 15 patent applications. Its first patent ever was published in 2009. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets medical technology, pharmaceuticals and optics are FUNDATECH SA, Universität Duisburg Essen and APAMED ANST.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | France | 1 | |
#6 | United Kingdom | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Optics |
# | Technology | |
---|---|---|
#1 | Implantable devices | |
#2 | Electrotherapy | |
#3 | Medical preparations | |
#4 | Syringes | |
#5 | Therapeutic chemical compounds | |
#6 | Spectacles | |
#7 | Optical systems |
# | Name | Total Patents |
---|---|---|
#1 | Manche Edward E | 11 |
#2 | Herekar Satish V | 11 |
#3 | Eaton Donald J | 11 |
#4 | Myung David | 4 |
#5 | Abbate Anthony J | 4 |
#6 | Blumenkranz Mark S | 2 |
Publication | Filing date | Title |
---|---|---|
CN106413642A | Vacuum-assisted drug delivery device | |
WO2012112543A2 | Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to scleral tissue | |
KR20130111932A | Method and apparatus for treatment of ocular tissue using combined modalities | |
EP2464387A2 | Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use | |
US2010057060A1 | In Situ UV/Riboflavin Ocular Treatment System |